Databases > DOI:10.25504/FAIRsharing.tamp4p

ready Parkinson's Progression Markers Initiative


General Information
PPMI is an observational clinical study to verify progression markers in Parkinson’s disease. The study is designed to establish a comprehensive set of clinical, imaging and biosample data that will be used to define biomarkers of PD progression. Once these biomarkers are defined, they can be used in therapeutic studies. The clinical, imaging and biologic data are accessible to researchers in real time through the website.

How to cite this record: PPMI; Parkinson's Progression Markers Initiative; DOI:; Last edited: Feb. 22, 2018, 2:58 p.m.; Last accessed: Mar 20 2018 7:32 a.m.

Record added: April 29, 2015, 9:24 p.m.
Record updated: Jan. 5, 2017, 4:03 p.m. by The FAIRsharing Team.


    No tools defined

Access / Retrieve Data

Conditions of Use

Applies to: Data use

Data Access


The Parkinson Progression Marker Initiative (PPMI).

Parkinson Progression Marker Initiative
Prog Neurobiol. 2011

View Paper (DOI)

Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI).

Nalls MA,Keller MF,Hernandez DG,Chen L,Stone DJ,Singleton AB
Mov Disord 2015

View Paper (PubMed) View Paper (DOI)

Related Standards

Reporting Guidelines

No guidelines defined

Terminology Artifacts

No semantic standards defined

Models and Formats

No syntax standards defined

Related Databases

Implementing Policies

This record is not implemented by any policy.


Record Maintainer

  • This record is in need of a maintainer. If you login, you'll be able to claim this record.